ACTA DERMATO-VENEREOLOGICA, published by the esteemed ACTA DERMATO-VENEREOLOGICA since 1945, stands as a leading open-access journal in the fields of Dermatology and Venereology. With an impressive Q1 categorization in both Dermatology and Miscellaneous Medicine, this journal ranks at the 82nd percentile among its peers, highlighting its pivotal role in disseminating cutting-edge research. Accessible to all since 1998, it provides a vital platform for sharing original studies, reviews, and insights on skin-related disorders and treatments, fostering knowledge expansion among researchers, professionals, and students alike. The journal's commitment to high-quality, peer-reviewed content ensures that it remains a trusted resource aimed at advancing dermatological science. Based in Uppsala, Sweden, ACTA DERMATO-VENEREOLOGICA continues to contribute significantly to the global discourse in dermatological health.

Dermatologic Surgery, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the field of dermatology, surgery, and medicine. With an impressive impact factor reflecting its significant contribution to the scientific community, this journal ranks in the top quartiles (Q2 in Dermatology and Medicine, Q1 in Surgery) and offers insights that are crucial for both clinical practice and academic research. Spanning a history from 1995 to 2024, it encompasses a wealth of knowledge on therapeutic advancements, surgical techniques, and innovative procedures pertinent to dermatologic surgery. Although it does not currently offer open access, the journal is highly respected among professionals and researchers, making it a key reference point for those engaged in cutting-edge dermatological care and research. Located in the heart of Philadelphia, Dermatologic Surgery is dedicated to enhancing the understanding and application of surgical dermatology through a rigorous peer-review process and a commitment to disseminating high-quality research.

Turkderm - Turkish Archives of Dermatology and Venerology, published by GALENOS PUBL HOUSE, serves as a vital platform for the dissemination of innovative research and advancements in the fields of dermatology and venerology. With an Open Access policy implemented since 2002, this journal aims to provide free and unrestricted access to significant findings, ensuring that vital information reaches a global audience. Based in Turkey, the journal has positioned itself as an important resource for professionals, researchers, and students alike, despite currently being categorized in Q4 of both Dermatology and Infectious Diseases as per the 2023 metrics. Although it faces competition in the rankings, with a Scopus standing of #131 in Dermatology and #331 in Infectious Diseases, its dedication to advancing knowledge in these critical health areas is unwavering. The journal continually invites original research, reviews, and case studies that enhance clinical practices and foster understanding in the dermatological community.

DERMATOLOGY, an esteemed journal published by KARGER, is a vital resource in the field of dermatological research and clinical practice. Established in 1893, with its comprehensive coverage extending to 2024, this journal has earned its place as a leading publication, holding a prestigious Q1 quartile ranking in Dermatology and ranking 15th out of 142 in the Scopus Medicine - Dermatology category, reflecting its 89th percentile standing within the discipline. The journal aims to disseminate innovative research findings, critical reviews, and clinical studies that advance the understanding of skin disorders and their treatments. While primarily available through institutional subscriptions, DERMATOLOGY remains committed to enhancing accessibility and fostering international collaboration among researchers, professionals, and students in the dermatological community. Its rigorous peer-review process guarantees the highest quality of published works, making it an essential reference for those dedicated to advancing dermatological science and improving patient care.

Welcome to the EUROPEAN JOURNAL OF PLASTIC SURGERY, a premier platform for the dissemination of cutting-edge research in the field of plastic and reconstructive surgery. Published by Springer, this journal boasts an ISSN of 0930-343X and an E-ISSN of 1435-0130, ensuring wide accessibility and recognition across the global scholarly community. With a focused scope dedicated to the advancements in surgical techniques, patient care, and innovative therapies, this journal plays a vital role in shaping the discourse and practices in the specialty. Notably ranked in the Q3 quartile of the Surgery category for 2023 and positioned at Rank #343 of 551 according to Scopus metrics, it represents a significant resource for practitioners and researchers alike. As the journal converges its publication efforts from 1986 through 2024, it continues to reflect on the evolving landscape of plastic surgery with insightful articles and studies. Although not an open access journal, it remains a cornerstone for those seeking to stay updated with the latest developments in surgical research and practices.

Journal of Dermatology & Dermatologic Surgery (JDDS) is a premier open access journal published by Wolters Kluwer Medknow Publications since 2018. This journal serves as a vital platform for the dissemination of cutting-edge research and advancements in the field of dermatology and dermatologic surgery. With its ISSN 2352-2410 and E-ISSN 2352-2429, JDDS strives to present high-quality articles that encompass clinical studies, innovative surgical techniques, and comprehensive reviews, thereby catering to the interests of researchers, medical professionals, and students alike. The journal has gained recognition within the academic community, evidenced by its Scopus ranks, placing it 237th out of 551 in the Medicine - Surgery category and 70th out of 142 in Medicine - Dermatology. The open access model not only enhances visibility but also encourages global collaboration and knowledge sharing in the rapidly evolving field of dermatology. Targeting the needs of diverse audiences, JDDS continues to foster an environment for scholarly communication and contributes significantly to the advancement of dermatologic sciences.

The JOURNAL OF DERMATOLOGICAL TREATMENT, published by TAYLOR & FRANCIS LTD, is a premier forum dedicated to advancing the field of dermatology through the dissemination of high-quality research. Since its inception in 1989, this journal has maintained a significant impact on the dermatological community, currently ranking in the top quartile (Q1) of the Dermatology category with an impressive Scopus ranking of #14 out of 142 journals, reflecting its reputation among peers and its contribution to the clinical and academic landscape. The journal shifted to Open Access in 2023, enhancing the accessibility of groundbreaking findings to researchers, clinicians, and students worldwide. With a commitment to publishing diverse articles, from innovative treatment modalities to comprehensive reviews, the JOURNAL OF DERMATOLOGICAL TREATMENT serves as an invaluable resource for professionals seeking to stay at the forefront of dermatological science in a rapidly evolving field.

The Journal of Cutaneous Immunology and Allergy, published by FRONTIERS MEDIA SA in Switzerland, is an esteemed Open Access platform dedicated to advancing research in the intersecting fields of dermatology, immunology, and allergy. Since its inception in 2018, this journal has provided a vital resource for the dissemination of innovative research findings and critical reviews, enhancing our understanding of cutaneous conditions related to immune responses. Although currently classified in the Q4 quartile in both Dermatology and Immunology & Allergy categories as of 2023, the journal continues to strive for recognition within the scientific community, encouraging collaboration and knowledge sharing among researchers, clinicians, and experts. The journal boasts an E-ISSN of 2574-4593 and is committed to making high-quality research freely accessible to all, thus fostering greater insights into the complexities of skin-related immune disorders. Join us in this journey to explore the forefront of cutaneous research and contribute to the evolving dialogue in this dynamic field.

Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.

CURRENT TREATMENT OPTIONS IN ONCOLOGY, published by Springer, is a premier academic journal dedicated to disseminating cutting-edge research and advancements in the field of oncology and pharmacology. With a commendable impact factor and ranked in the Q1 category in both oncology and pharmacology for 2023, this journal positions itself as a leading resource for researchers, healthcare professionals, and students alike, offering insightful reviews and original articles that critically evaluate treatment methodologies and clinical practices. Covering a wide scope of topics from early detection to innovative therapies, it fosters the translation of research findings into clinical applications. With its convergence years spanning from 2000 to 2024, CURRENT TREATMENT OPTIONS IN ONCOLOGY continues to be at the forefront of oncological research, providing a platform for scholars to explore the latest therapeutic options and improve patient outcomes. Highly regarded in the academic community, this journal is essential for anyone looking to stay informed about the dynamic landscape of cancer treatment.